← For Researchers/Menopause/Research Sites

Menopause Research Sites

Sites currently running trials · ranked by activity

Endometriosis Long COVID ALS PTSD Sickle Cell Disease Lupus Prostate Cancer Menopause Lp(a)

158 sites · 161 trials · September 2026

Recruiting

Opening soon

Active · not recruiting

Memorial Sloan Kettering Cancer Center

New York · New York · United States

2 trials

Study tracks bone health changes in postmenopausal breast cancer patients after stopping denosumab and aromatase inhibitor treatment.

Memorial Sloan Kettering Cancer CenterRecruitingNCT05590949 ↗

Aerobic exercise interventions improving heart health in postmenopausal breast cancer survivors.

Memorial Sloan Kettering Cancer CenterRecruitingNCT04458532 ↗

School of Psychology, Northumbria University

Newcastle upon Tyne · United Kingdom

2 trials

Multivitamin supplementation improving menopause symptoms, cognition, sleep, and mood in perimenopausal women.

Northumbria UniversityNCT07242430 ↗

Magnesium supplementation reducing menopause symptoms, improving cognition and sleep in perimenopausal women.

Northumbria UniversityNCT07235878 ↗

Mayo Clinic in Rochester

Rochester · Minnesota · United States

2 trials

Hot flashes in women are linked to neurovascular dysfunction and increased cardiovascular disease risk.

Mayo ClinicRecruitingNCT05193968 ↗

Menopausal hormone therapy's effects on heart function and stroke volume responses in postmenopausal women.

Mayo ClinicRecruitingNCT07242391 ↗

Novum Pharmaceutical Research Services

Las Vegas · Nevada · United States

1 trial

Estradiol/levonorgestrel transdermal patch tested for skin irritation and allergic reactions in postmenopausal women.

Corium Innovations, Inc.Ph 1RecruitingNCT07794150 ↗

Lambda Therapeutic Research Ltd.

Ahmedabad · Gujarat · India

1 trial

Estradiol/levonorgestrel transdermal patch tested for skin irritation and allergic reactions in postmenopausal women.

Corium Innovations, Inc.Ph 1Opening soonNCT07794150 ↗

St Mary's University

London · United Kingdom

1 trial

Daily omega-3 supplements tested for improving memory and cognitive function in perimenopausal and menopausal women aged 40-60.

St. Mary's University, TwickenhamNCT07814300 ↗

Acıbadem Bursa Hospital

Bursa · Turkey (Türkiye)

1 trial

Menopausal hormone therapy observed for effects on breast imaging and blood vessel health in postmenopausal women.

Sanliurfa Mehmet Akif Inan Education and Research HospitalRecruitingNCT07810959 ↗

Benha University Hospital

Banhā · Qalyubia Governorate · Egypt

1 trial

Platelet-rich plasma injections into urethra tested for treating stress urinary incontinence in postmenopausal women.

Benha UniversityNCT07807982 ↗

Rutgers Cancer Institute

New Brunswick · New Jersey · United States

1 trial

Low-dose tamoxifen at shortened duration tested to reduce breast cancer risk in high-risk postmenopausal women.

Rutgers, The State University of New JerseyPh 2NCT07806630 ↗

İstanbul Medipol University Mega Hospital

Istanbul · Mrs · Turkey (Türkiye)

1 trial

Mobile game-based cognitive intervention tested for reducing brain fog and improving well-being in menopausal women aged 45-55.

Medipol UniversityNCT07800793 ↗

Recruitment site (to be specified), Konya

Konya · Turkey (Türkiye)

1 trial

Cross-sectional study examining whether menopausal symptom severity predicts religious orientation in menopausal women.

KTO Karatay UniversityRecruitingNCT07797296 ↗

Fondazione IRCCS Policlinico San Matteo di Pavia

Pavia · Lombardy · Italy

1 trial

Study investigating prevalence of autoimmune and immune-mediated conditions in women aged 40-60 during menopausal transition.

Fondazione IRCCS Policlinico San Matteo di PaviaNCT07784400 ↗

Ankara University

Ankara · Altindağ · Turkey (Türkiye)

1 trial

Audio-described menopause education program tested for improving menopause knowledge in visually impaired women.

Ankara UniversityNCT07771946 ↗

Skåne Universitetssjukhus

Malmö · Skåne County · Sweden

1 trial

Romosozumab followed by denosumab versus zoledronic acid for increasing bone density in osteoporosis patients at high fracture risk.

Sahlgrenska University HospitalPh 4NCT07772609 ↗

Karolinska University Hospital Huddinge

Huddinge · Stockholm County · Sweden

1 trial

Romosozumab followed by denosumab versus zoledronic acid for increasing bone density in osteoporosis patients at high fracture risk.

Sahlgrenska University HospitalPh 4NCT07772609 ↗

Sabbatsbergs sjukhus

Stockholm · Stockholm County · Sweden

1 trial

Romosozumab followed by denosumab versus zoledronic acid for increasing bone density in osteoporosis patients at high fracture risk.

Sahlgrenska University HospitalPh 4NCT07772609 ↗

Akademiska sjukhuset

Uppsala · Uppsala County · Sweden

1 trial

Romosozumab followed by denosumab versus zoledronic acid for increasing bone density in osteoporosis patients at high fracture risk.

Sahlgrenska University HospitalPh 4NCT07772609 ↗

Norrlands universitetssjukhus

Umeå · Västerbotten County · Sweden

1 trial

Romosozumab followed by denosumab versus zoledronic acid for increasing bone density in osteoporosis patients at high fracture risk.

Sahlgrenska University HospitalPh 4NCT07772609 ↗

Sundsvalls sjukhus

Sundsvall · Västernorrland County · Sweden

1 trial

Romosozumab followed by denosumab versus zoledronic acid for increasing bone density in osteoporosis patients at high fracture risk.

Sahlgrenska University HospitalPh 4NCT07772609 ↗

Sahlgrenska University Hospital Mölndal

Mölndal · Västra Götaland County · Sweden

1 trial

Romosozumab followed by denosumab versus zoledronic acid for increasing bone density in osteoporosis patients at high fracture risk.

Sahlgrenska University HospitalPh 4NCT07772609 ↗

Skaraborgs sjukhus

Skövde · Västra Götaland County · Sweden

1 trial

Romosozumab followed by denosumab versus zoledronic acid for increasing bone density in osteoporosis patients at high fracture risk.

Sahlgrenska University HospitalPh 4NCT07772609 ↗

Linköping University Hospital

Linköping · Östergötland County · Sweden

1 trial

Romosozumab followed by denosumab versus zoledronic acid for increasing bone density in osteoporosis patients at high fracture risk.

Sahlgrenska University HospitalPh 4NCT07772609 ↗

İnönü Üniversitesi

Malatya · Turkey (Türkiye)

1 trial

Therapeutic touch and foot reflexology improve sleep quality and menopausal symptoms in earthquake-affected postmenopausal women.

Osmaniye Korkut Ata UniversityNCT07767318 ↗

Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University

Boston · Massachusetts · United States

1 trial

Dietary stearic acid's effects on gut bacteria composition and bile acid metabolism compared to palmitic acid in healthy adults.

Tufts UniversityNCT07766915 ↗

Spectrum Clinical Research

Kansas City · Missouri · United States

1 trial

Fermented soy product Haelan 951 reduces hot flashes, improves sleep, and quality of life in menopausal women.

Spectrum Clinical Research, LLCRecruitingNCT07751029 ↗

University of Missouri-Columbia

Columbia · Missouri · United States

1 trial

Blood vessel responses to low oxygen in premenopausal, perimenopausal, and postmenopausal women with varying beta-adrenergic receptor involvement.

University of Missouri-ColumbiaPh 1 (early)RecruitingNCT06417177 ↗

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Basking Ridge · New Jersey · United States

1 trial

Study tracks bone health changes in postmenopausal breast cancer patients after stopping denosumab and aromatase inhibitor treatment.

Memorial Sloan Kettering Cancer CenterRecruitingNCT05590949 ↗

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Middletown · New Jersey · United States

1 trial

Study tracks bone health changes in postmenopausal breast cancer patients after stopping denosumab and aromatase inhibitor treatment.

Memorial Sloan Kettering Cancer CenterRecruitingNCT05590949 ↗

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale · New Jersey · United States

1 trial

Study tracks bone health changes in postmenopausal breast cancer patients after stopping denosumab and aromatase inhibitor treatment.

Memorial Sloan Kettering Cancer CenterRecruitingNCT05590949 ↗

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)

Commack · New York · United States

1 trial

Study tracks bone health changes in postmenopausal breast cancer patients after stopping denosumab and aromatase inhibitor treatment.

Memorial Sloan Kettering Cancer CenterRecruitingNCT05590949 ↗

Memorial Sloan Kettering Westchester (Limited Protocol Activities)

Harrison · New York · United States

1 trial

Study tracks bone health changes in postmenopausal breast cancer patients after stopping denosumab and aromatase inhibitor treatment.

Memorial Sloan Kettering Cancer CenterRecruitingNCT05590949 ↗

Memorial Sloan Kettering Nassau (Limited Protocol Activities)

Uniondale · New York · United States

1 trial

Study tracks bone health changes in postmenopausal breast cancer patients after stopping denosumab and aromatase inhibitor treatment.

Memorial Sloan Kettering Cancer CenterRecruitingNCT05590949 ↗

Washington University School of Medicine

St Louis · Missouri · United States

1 trial

Ovarian-sparing radiation technique preserves ovarian function in young women with pelvic cancers undergoing radiotherapy.

Washington University School of MedicineRecruitingNCT06904365 ↗

University of Michigan School of Kinesiology

Ann Arbor · Michigan · United States

1 trial

Resistance training improves blood vessel health and mood in women entering menopause.

University of MichiganRecruitingNCT07022340 ↗

NIHR Southampton Clinical Research Facility

Southampton · Hampshire · United Kingdom

1 trial

Nutritional supplement with myo-inositol, berberine, cinnamon, and chromium changes body composition in middle-aged women.

University of SouthamptonRecruitingNCT07615777 ↗

Department of Physical Education and Sport Science, University of Thessaly

Trikala · Karies · Greece

1 trial

Dance exercise training improves metabolic health, mental health, and physical performance across all age groups.

University of ThessalyRecruitingNCT07615829 ↗

GSSI Bradenton

Bradenton · Florida · United States

1 trial

Hydration patterns and effects vary across female life stages from premenopause through postmenopause.

PepsiCo Global R&DRecruitingNCT07653620 ↗

GSSI Valhalla

Valhalla · New York · United States

1 trial

Hydration patterns and effects vary across female life stages from premenopause through postmenopause.

PepsiCo Global R&DRecruitingNCT07653620 ↗

Gulbenkian Institute for Molecular Medicine, Lisbon

Lisbon · Portugal

1 trial

Gut microbiome changes relate to hormonal changes during menopause in women aged 40-64.

Gulbenkian Institute for Molecular MedicineRecruitingNCT07614542 ↗

Bursa Osmangazi Geçit Aile Sağlığı Merkezi

Bursa · Turkey (Türkiye)

1 trial

Avatar-based education program increases spousal support for menopausal women.

Eskisehir Osmangazi UniversityRecruitingNCT07599319 ↗

Department of Physiotherapy. University of Valencia

Valencia · Spain

1 trial

Muscle training and education reduce menopausal symptoms in women without hormones or medications.

University of ValenciaRecruitingNCT06419972 ↗

Laura Fuentes Aparicio

Valencia · Spain

1 trial

Muscle training and education reduce menopausal symptoms in women without hormones or medications.

University of ValenciaOpening soonNCT06419972 ↗

University of Miami

Miami · Florida · United States

1 trial

Platelet-rich plasma injections improve menopausal genitourinary symptoms in breast cancer survivors.

University of MiamiPh 2NCT05812924 ↗

Gothenburg university

Gothenburg · Sweden

1 trial

High-intensity focused electromagnetic stimulation treats urinary incontinence in postmenopausal women.

Göteborg UniversityNCT07260604 ↗

Goldring Centre for High Performance Sport

Toronto · Ontario · Canada

1 trial

Different exercise training types reduce menopause symptoms and cardiovascular disease risk in women transitioning to menopause.

University of TorontoRecruitingNCT07132385 ↗

Precision NextGen Oncology and Research Center (Investigational Site number USA-001)

Beverly Hills · California · United States

1 trial

Quarterly injection letrozole versus daily oral letrozole bioavailability in postmenopausal women with hormone receptor-positive breast cancer.